An ADRENERGIC BETA-2 RECEPTOR AGONIST with a prolonged duration of action. It is used to manage ASTHMA and in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
Formoterol Fumarate has been studied across 10 research domains including 🫁 Respiratory, 🫁 Liver & Detox, 🫘 Kidney, 🔬 Inflammation, ⏳ Longevity & Aging. The primary research focus is 🫁 Respiratory with 92% of studies addressing this area.
This evidence profile for Formoterol Fumarate is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.